How Listeria monocytogenes adapts to oxidative stress

Metabolic changes that promote adaptation of Listeria monocytogenes to oxidative stress and preserving intracellular redox homeostasis

NIH-funded research Mississippi State University · NIH-10793915

This study is looking at how the bacteria that causes listeriosis, a serious foodborne illness, manages to survive in our bodies when faced with harmful substances, and it hopes to find new ways to help treat infections for people who get sick from it.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionMississippi State University NIH-funded
Lab location1 site (Mississippi State, United States)
Project IDNIH-10793915 on NIH RePORTER

What this research studies

This research investigates how the bacteria Listeria monocytogenes, which causes a serious foodborne illness, adapts its metabolism to survive oxidative stress during infection. The study focuses on understanding the metabolic pathways that the bacteria use to counteract harmful reactive oxygen species in the host environment. By analyzing specific metabolites and the role of a protein called FruR, the researchers aim to uncover new strategies for treating infections caused by this pathogen. This could lead to improved therapeutic approaches for patients suffering from listeriosis.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals who have been diagnosed with listeriosis or are at high risk for severe infections caused by Listeria monocytogenes.

Not a fit: Patients with non-infectious conditions or those not affected by Listeria monocytogenes will not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to the development of more effective treatments for listeriosis, potentially reducing mortality rates associated with this infection.

How similar studies have performed: While the specific metabolic adaptations of Listeria monocytogenes to oxidative stress are being explored in this research, similar studies on bacterial resistance mechanisms have shown promising results in the past.

Where this research is happening

Mississippi State, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.